John Steel

About John Steel

Senior operating executive with 20+ years of experience building and scaling B2B life sciences and clinical diagnostics businesses in highly regulated global markets. Proven track record translating innovation, automation, and regulatory complexity (IVDD, IVDR, FDA 510(k)) into durable, scalable platforms.Serve in senior leadership and general management roles across Biocare Medical and Empire Genomics, with full P&L responsibility and ownership of commercial strategy, product management, marketing, and platform execution.Selected impact and outcomes:• Led the launch of every fully automated platform at Biocare Medical, resulting in instrument placements worldwide• Built and scaled global automation programs driving long-term consumables pull-through and recurring revenue models• Expanded combined IHC, ISH, FISH, and molecular portfolios to support hundreds of products and one of the industry’s broadest FISH probe menus• Executed global go-to-market strategies across direct, distributor, and OEM channels• Advanced IVDR readiness and regulatory execution to protect EU market access and long-term portfolio durabilityKnown for operating at the intersection of strategy and execution—aligning R&D, Quality/Regulatory, Operations, and Commercial teams to scale platforms, improve operating leverage, and deliver strong customer outcomes. Particularly effective in B2B diagnostics models that combine instruments, consumables, and services.

Experience

1. Senior Vice President, General Manager

   Empire Genomics

   May 2025 — Present · Buffalo, NY, US

   Senior executive with full P&L ownership, leading the commercial and operational scale-up of Empire Genomics, a global provider of FISH and molecular diagnostic solutions.Drive revenue growth, portfolio expansion, automation strategy, and global commercialization across clinical and research markets. Own product strategy, pricing, channel development, OEM partnerships, and IVDR readiness while building one of the industry’s largest FISH probe menus.Operate at the intersection of strategy and execution - translating innovation, regulatory complexity, and market opportunity into measurable growth.